Credit Suisse’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $20.6M | Sell |
|
|||||
|
2023
Q4 | $26.1M | Buy |
|
|||||
|
2023
Q3 | $21M | Sell |
|
|||||
|
2023
Q2 | $29.6M | Sell |
|
|||||
|
2023
Q1 | $34.7M | Buy |
|
|||||
|
2022
Q4 | $41.5M | Sell |
|
|||||
|
2022
Q3 | $40.6M | Buy |
|
|||||
|
2022
Q2 | $27.6M | Sell |
|
|||||
|
2022
Q1 | $25.9M | Buy |
|
|||||
|
2021
Q4 | $37.5M | Sell |
|
|||||
|
2021
Q3 | $56.2M | Buy |
|
|||||
|
2021
Q2 | $58M | Buy |
|
|||||
|
2021
Q1 | $77.1M | Buy |
|